Breast Cancer

• CLINICAL_TRIALS other · 2025-11-19
  Clinical Trial Update: Study of AVZO-021 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

  This clinical trial update shows AVZO-021 is in Phase 1/2 for advanced solid tumors including HR+/HER2- breast cancer and several gynecologi…

• CLINICAL_TRIALS other · 2025-11-19
  Clinical Trial Update: Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support [NA]

  Clinical trial entry describing a study to prevent therapy-related cardiovascular toxicity in breast cancer patients using a daily-adapted p…

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection [Phase 3]

  A Phase 3 trial investigating palbociclib and circulating tumor DNA ESR1 mutation detection in metastatic breast cancer has completed.

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.

  A Pfizer-sponsored study comparing palbociclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in Medicare pa…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer [Phase 2]

  Phase 2 clinical trial evaluating iparomlimab and tuvonralimab (QL1706) in HR-positive, HER2-negative advanced breast cancer is currently re…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer [Phase 3]

  A Phase 3 trial is evaluating continuous or intermittent extension of adjuvant pyrotinib for invasive HER2-positive breast cancer.

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer [NA]

  This clinical trial tests a targeted palliative care intervention for patients with metastatic breast cancer and is currently recruiting.

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease [Phase 2]

  Phase 2 clinical trial evaluating capecitabine, tucatinib, and intrathecal trastuzumab for leptomeningeal metastasis/disease in HER2-positiv…

• CLINICAL_TRIALS withdrawal · 2025-11-18
  Clinical Trial Update: Cervical Motor Control in Long-term Breast Cancer Survivors [NA]

  A clinical trial from Universidad de Granada studying cervical motor control in long-term breast cancer survivors has been withdrawn.

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO) [NA]

  This completed clinical trial (ATENTO) evaluated adjusting the dose of therapeutic exercise to prevent neurotoxicity from anticancer treatme…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Hypofractionated LocoRegional Radiotherapy in Breast Cancer [Phase 3]

  Phase 3 trial status update indicates hypofractionated loco-regional radiotherapy for breast cancer is active but not recruiting.

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Trastuzumab Deruxtecan in Advanced Breast Cancer

  A clinical trial update indicates that a study evaluating trastuzumab deruxtecan for advanced breast cancer is currently recruiting.

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer [Phase 1]

  Phase 1 trial of DS8201a (trastuzumab deruxtecan) in combination with pembrolizumab for locally advanced/metastatic breast cancer or non-sma…

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy [NA]

  A completed clinical trial comparing quality of recovery between PECS block regional anesthesia and general anesthesia in breast-conserving …

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Study of Sexual Quality of Life in Women With Breast Cancer Who Had Multidisciplinary Management With Photobiomodulation for Genitourinary Syndrome of the Menopause [NA]

  A study evaluating sexual quality of life in women with breast cancer who received multidisciplinary management including photobiomodulation…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program [NA]

  A clinical trial sponsored by Universidad de Granada is evaluating the PRESIONA exercise program to prevent chemotherapy-induced peripheral …

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy

  Clinical trial update describing a study that investigates omitting radiation therapy for patients with clinically node-negative breast canc…

• CLINICAL_TRIALS trial_result · 2025-11-18
  Clinical Trial Update: Early Detection of Cardiotoxicity From Systemic and Radiation Therapy in Breast Cancer Patients

  This completed clinical trial update describes methods for early detection of cardiotoxicity caused by systemic and radiation therapy in bre…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer [Phase 2]

  A Phase 2 study is evaluating continuous or intermittent dosing of pyrotinib in HER2-positive advanced breast cancer, and the trial is curre…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer

  This ClinicalTrials.gov update describes a study evaluating sleep quality in prostate cancer patients receiving hormonal therapy and in pati…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Low Dose Exemestane vs Low Dose Tamoxifen in Post-menopausal Women at High Risk for Breast Cancer. [Phase 2]

  A Phase 2 clinical trial is comparing low-dose exemestane with low-dose tamoxifen in post-menopausal women at high risk for breast cancer an…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Korea Post Marketing Surveillance (PMS) Study of Talzenna®

  This is a Korea post-marketing surveillance study for Talzenna (talazoparib) focusing on breast cancer; the trial is currently not yet recru…

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer [NA]

  A completed clinical trial evaluating whether CK+/CD45+ double-positive circulating cells are of tumor origin in metastatic breast cancer.

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted Risk [NA]

  A clinical trial update investigates arm swelling (lymphedema) in breast cancer patients receiving nodal radiotherapy and whether informing …

• CLINICAL_TRIALS research · 2025-11-18
  Clinical Trial Update: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors [Phase 2]

  This clinical trial update describes a Phase 2 study evaluating MHB036C in combination with MHB039A in patients with advanced breast cancer …